Cargando…
Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis
OBJECTIVES: The optimal surgical resection method for hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT) that maximizes both safety and long-term outcome has not yet been determined. The aim of this study was to compare the clinical outcomes following peeling off versus e...
Autores principales: | Zhang, Yong-Fa, Le, Yong, Wei, Wei, Zou, Ru-Hai, Wang, Jia-Hong, OuYang, Han-Yue, Xiao, Cheng-Zuo, Zhong, Xiao-Ping, Shi, Ming, Guo, Rong-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122434/ https://www.ncbi.nlm.nih.gov/pubmed/27072577 http://dx.doi.org/10.18632/oncotarget.8642 |
Ejemplares similares
-
A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
por: XIAO, CHENG-ZUO, et al.
Publicado: (2015) -
Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus
por: Zhang, Yong-Fa, et al.
Publicado: (2016) -
Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis
por: Wang, Kang, et al.
Publicado: (2016) -
Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, (125)I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus
por: Zhao, Xiao-Hui, et al.
Publicado: (2023) -
Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis
por: Zhang, Zi-Han, et al.
Publicado: (2023)